Related Experiment Videos
[Anticardiolipin antibodies in patients with cerebral ischemia]
W Palasik1, M Meurer, M Palester-Chlebowczyk
1Kliniki Chorób Naczyniowych Układu Nerwowego Instytutu Psychiatrii i Neurologii, Warszawie.
Insights
High levels of anticardiolipin antibodies were linked to ischemic strokes and transient ischemic attacks in six patients. These antibodies may represent a significant risk factor for stroke development.
Area of Science:
- Neurology
- Immunology
- Vascular Medicine
Background:
- Anticardiolipin antibodies (aCL) are associated with autoimmune conditions.
- Their role in cerebrovascular events requires further elucidation.
Observation:
- Six patients presenting with ischemic strokes or transient ischemic attacks (TIAs) had high levels of anticardiolipin antibodies.
- Clinical presentations varied, including recurrent ischemic episodes, late-onset stroke, and generalized vascular involvement in two female patients.
Findings:
- A correlation between elevated anticardiolipin antibodies and cerebrovascular events like stroke and TIA was observed.
- The specific mechanisms by which aCL contribute to central nervous system vascular pathology remain unclear.
Implications:
- Anticardiolipin antibodies may be a potential risk factor for stroke.
- Further research is warranted to understand the pathogenic role of aCL in cerebrovascular disease.
Abstract:
Six patients with high level of anticardiolipin antibodies were hospitalized for ischaemic strokes or transient ischaemic attacks. The clinical findings in these cases varied greatly. In three ischaemic episodes were recurrent. In two stroke developed at old age without prodromal symptoms. In two females the vascular involvement was generalized. Although the role of anticardiolipin antibodies in the pathogenesis of vascular changes of the central nervous system is not yet clear it is thought that they may be a risk factor for stroke.